Trial Profile
Clinical Trials Insight: 700028283
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 May 2011
Price :
$35
*
At a glance
- Drugs AR 9281 (Primary)
- Indications Hypertension; Metabolic syndrome; Type 2 diabetes mellitus
- Focus Adverse reactions; Biomarker; Pharmacokinetics
- Sponsors Arete Therapeutics
- 23 Dec 2008 Status changed from planning to completed, as reported in an Arete Therapeutics media release.
- 18 Dec 2008 Results announced in an Arete Therapeutics media release.
- 08 Nov 2007 New trial record.